ArticleJournal of experimental & clinical cancer research : CR2022

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

Maria Serena Roca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.